Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Camille Goyer"'
Autor:
Tara Gonzales, Aurore Bergamasco, Tiffany Cristarella, Camille Goyer, Matthew Wojdyla, Abiola Oladapo, John Sawicky, John Yee, Yola Moride
Publikováno v:
American Journal of Perinatology.
Objective Palivizumab is a humanized monoclonal antibody approved for the prevention of serious lower respiratory tract infection (LRTI) caused by respiratory syncytial virus (RSV) in infants and young children at high risk of RSV disease. This syste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::127c7b8a281daf52b57c5a3ec1f0df3c
https://doi.org/10.1055/a-1990-2633
https://doi.org/10.1055/a-1990-2633
Publikováno v:
International Journal of Environmental Research and Public Health; Volume 19; Issue 9; Pages: 5122
In Canada, interventions and policies have been implemented to minimize the risk of opioid-related harms. This mixed methods study aimed at describing trends over time in implementation, as well as in awareness and health outcomes. For implementation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0808ba43aab13ee090deb3497f5db88
https://doi.org/10.3390/ijerph19095122
https://doi.org/10.3390/ijerph19095122
Autor:
Du, Ping (AUTHOR), Cristarella, Tiffany (AUTHOR), Goyer, Camille (AUTHOR), Moride, Yola (AUTHOR)
Publikováno v:
Journal of Blood Medicine. Aug2024, Vol. 15, p363-386. 24p.
Publikováno v:
Pharmacoepidemiology & Drug Safety; Oct2023 Supplement 1, Vol. 32, p3-612, 610p
Publikováno v:
International Journal of Environmental Research & Public Health; May2022, Vol. 19 Issue 9, p5122-5122, 12p
Publikováno v:
Pharmacoepidemiology & Drug Safety; Oct2020 Supplement S3, Vol. 29, p3-634, 632p